Lenvatinib
Lenvatinib is a multi-target inhibitor, mostly for VEGFR2(KDR)/VEGFR3(Flt-4) with IC50 of 4 nM/5.2 nM, less potent against VEGFR1/Flt-1, ~10-fold more selective for VEGFR2/3 against FGFR1, PDGFRα/β in cell-free assays. Lenvatinib (E7080) also inhibits FGFR1-4, PDGFR, Kit (c-Kit), RET (c-RET), and shows potent antitumor activities. Phase 3.
| Trivial name | E7080 |
| Catalog Number | S1164 |
| Molecular Formula | C22H17Cl2F6N3O3 |
| CAS# | 417716-92-8 |
| Inchi | InChI=1S/C22H17Cl2F6N3O3/c1-11-4-12(2-3-16(11)19(35)31-9-18(34)32-10-21(25,26)27)17-8-20(36-33-17,22(28,29)30)13-5-14(23)7-15(24)6-13/h2-7H,8-10H2,1H3,(H,31,35)(H,32,34) |
| Inchi Key | MLBZKOGAMRTSKP-UHFFFAOYSA-N |
| SMILES | CC1=C(C=CC(=C1)C2=NOC(C2)(C3=CC(=CC(=C3)Cl)Cl)C(F)(F)F)C(=O)NCC(=O)NCC(F)(F)F |
| Size | 5mg |
| Supplier Page | http://www.selleckchem.com/products/E7080.html |
| Additional Information | https://file.selleck.cn/downloads/struct/E7080-chemical-structure-S1164.gif |